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ABSTRACT 
New technologies for the purification of stable membrane proteins have emerged in recent years, 
in particular methods that allow the preparation of membrane proteins with their native lipid 
environment. Here, we look at the progress achieved with the use of styrene-maleic acid 
copolymers (SMA) which are able to insert into biological membranes forming nanoparticles 
containing membrane proteins and lipids. This technology can be applied to membrane proteins 
from any host source, and, uniquely, allows purification without the protein ever being removed 
from a lipid bilayer. Not only do these SMA lipid particles (SMALPs) stabilise membrane proteins, 
allowing structural and functional studies, but they also offer opportunities to understand the local 
lipid environment of the host membrane. With any new or different method, questions inevitably 
arise about the integrity of the protein purified: does it retain its activity; its native structure; and 
ability to perform its function? How do membrane proteins within SMALPS perform in existing 
assays and lend themselves to analysis by established methods? We outline here recent work on 
the structure and function of membrane proteins that have been encapsulated like this in a polymer-
bound lipid bilayer, and the potential for the future with this approach. 
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● Styrene maleic acid copolymers form self-assembling lipid particles (SMALPs) with lipids 
and proteins directly from biological membranes and provide an alternative to conventional 
detergents for membrane protein solubilisation. 
● SMALPs enable purification and study of membrane protein structure and function whilst 
retaining their lipid bilayer environment. 
●  Membrane proteins are typically functional and highly stable in SMALPs. 
● Many established methods for functional and structural characterisation of proteins are 
compatible with SMALPs. 
● SMALPs offer the opportunity to study the interactions between membrane proteins and 
their native lipids. 
: 
Styrene maleic acid lipid particle (SMALP) 
Membrane proteins 
Nanodiscs 
Lipid bilayer 
detergent-free 
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: 
SMA  styrene-maleic acid copolymer 
SMALP SMA lipid particle 
MSP  membrane scaffolding protein 
GPCR  G protein-coupled receptor 
ABC  ATP binding cassette 
hENT1 human equilibrative nucleoside transporter 1 
CzcD  zinc diffusion facilitator 
NMR  nuclear magnetic resonance 
CHS  cholesteryl hemisuccinate 
A2AR  adenosine 2a receptor 
MT1R  melatonin receptor 
TLC  thin layer chromatography 
MS  mass spectrometry 
PC  phosphatidylcholine 
PE  phosphatidylethanolamine 
PG  phosphatidylglycerol 
CL  cardiolipin 
CD  circular dichroism spectroscopy 
DDM  dodecylmaltoside 
OG  octylglucoside 
DM  decylmaltoside 
EM  electron microscopy 
LCP  lipidic cubic phase 
HwBR  bacteriorhodopsin from Haloquadratum walsbyi 
FRET  Fӧrster resonance energy transfer 
DIBMA di-isobutylene maleic acid copolymer 
SMA-SH SMA with solvent exposed sulphydryls 
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INTRODUCTION 
Membrane proteins are encoded by approximately 30% of the human genome and are vitally 
important for the function of a cell[1]. Transporters and channels control what enters and leaves, 
whilst receptors are responsible for communication between different cells. Membrane proteins 
can also have important enzymatic or structural functions. Due to these crucial roles, the 
dysfunction of numerous membrane proteins are associated with a wide range of human diseases, 
and they provide potential therapeutic targets for many conditions. However, their location within 
a membrane lipid bilayer has meant that the study of the structure and function of these very 
important proteins lags behind that of easier-to-isolate, soluble proteins. 
While a biological membrane is a complex and dynamic mixture of many different lipids and 
proteins, in order to study an individual protein it must be removed from the membrane.  
Traditionally this has been solved with detergents, which simultaneously solubilise membrane 
proteins by substituting for their lipids in hydrophobic regions of the protein and presenting a 
hydrophilic surface to aqueous solutions[2]. However this approach is challenging; finding the 
right balance between efficient extraction and maintenance of protein structure and function 
requires a time consuming and costly screening approach, which is highly protein specific. Many 
proteins lose activity in detergent solution, perhaps due to loss of the lateral pressure usually 
provided by the membrane[3], because the detergents can also denature stabilising interactions 
within the protein itself, or because vital lipids required for protein function have been stripped 
away. The membrane is not simply a hydrophobic ‘sea’ within which membrane proteins are 
distributed, but specific interactions occur between certain lipids and proteins, and the function of 
many membrane proteins is highly dependent on the specific lipid environment in which they are 
located[4–6]. To try to combat this issue following detergent-mediated purification, proteins have 
been reconstituted back into lipid bilayer systems, in order to reproduce the lipid environment for 
downstream functional studies. Most frequently this has involved the formation of 
proteoliposomes. However this can result in high lipid:protein ratios, and the large 
proteoliposomes scatter light, which can be problematic for some downstream techniques. The 
development of nanodiscs provided a step change in reconstitution of membrane proteins[7]. In 
nanodiscs membrane proteins are reconstituted into a small disc of lipid bilayer surrounded by a 
membrane scaffolding protein (MSP). These particles are small (approx.10nm diameter) and stable 
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and have been shown to be amenable for numerous downstream techniques[8]. However, they do 
still require initial solubilisation and purification using detergents. 
 
SMALPs – what is new and different about them? 
A new approach to membrane protein extraction has been developed utilising a styrene-maleic 
acid (SMA) copolymer instead of conventional detergents. This polymer inserts into membranes 
and ‘cuts it up’ to form small discs of bilayer encircled by the polymer, termed SMALPs (SMA 
lipid particles) (Figure 1), also known as native nanodiscs and lipodisqs. SMA is amphipathic due 
to its mixture of hydrophobic styrene and charged, hydrophilic maleic acid moieties. So far, SMA 
polymers with both 2:1 and 3:1 styrene:maleic acid ratios have been used successfully. 
Importantly, membrane proteins extracted by this polymer retain their lipid bilayer environment, 
yet the particles are small (approx.10nm diameter), stable, soluble and amenable to many 
downstream techniques[9–13]. SMA encapsulated proteins can be purified using affinity 
chromatography, meaning you can extract, purify and study your membrane protein of interest 
without ever removing it from its lipid bilayer environment (Figure 1). 
SMA is not the first foray into using amphipathic polymers for membrane protein stabilisation; 
this approach was pioneered in the 1990s by Jean-Luc Popot and co-workers[14,15]. However, 
SMA is the first polymer shown to be capable of directly solubilising biological membranes. In 
fact, it could be argued that the membrane proteins remain solubilised in their native lipids, while 
SMA allows the lipids to be soluble in aqueous solution.  
  
What is SMA and how does it work? 
In many ways it is remarkable that a crude industrial product can facilitate the purification of 
monodisperse samples of membrane proteins. As a result of its synthesis by free-radical 
polymerisation[16], the SMA currently used for protein purification is a random copolymer and is 
fundamentally polydisperse (polydispersity index = 2.8)[17], consisting of polymers of different 
lengths and compositions. The ratio of styrene:maleic acid in each case (i.e. 2:1, 3:1 etc) refer to 
an average across a whole batch, rather than indicating strict alternation of -[S-S-M] sections. It is 
yet to be determined what subset of the total polymer mixture is actually active in forming 
SMALPs. Likewise, the number of SMA polymers encircling the lipid is controversial. Despite 
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these uncertainties, SMA has already enabled the purification and analysis of a long list of 
membrane proteins[18]. 
Aside from its ability to solubilise biological membranes, SMA does not form micelles in the way 
that they are understood for conventional head-and-tail detergents. This means that the polymer is 
used only for solubilisation and does not have to be added to buffers for the remaining steps of the 
purification. This is both convenient and removes many difficulties associated with the presence 
of micelles (eg interference with light scattering methods, excessive concentration of large 
micelles). 
The solubilisation of model lipid vesicles by SMA has been used to start to answer some of the 
mechanistic questions about how SMA works. Keller and co-workers have demonstrated that 
thermodynamically, SMALP formation incurs a much lower free energy penalty than 
solubilisation by conventional detergents. Whilst SMA has a thermodynamic preference for being 
within SMALPs, the lipids display little preference between SMALPs and vesicular bilayers, thus 
highlighting their more native-like properties[19,20]. Factors that affect the kinetics of 
solubilisation have also been investigated. SMA solubilisation is faster when lipid chain lengths 
are shorter, lateral pressure is low, ionic strength is increased or the temperature is increased, 
particularly above the melting temperature (Tm) of the lipid bilayer[21]. However the kinetic 
efficiencies obtained do not correlate with thermodynamic efficiency, in that slow solubilisation 
of gel-phase bilayers actually requires less SMA than the fast solubilisation of fluid-phase 
bilayers[19]. Thus there are still many questions remaining to be answered to fully understand the 
mechanism of SMA solubilisation of lipids. It also remains to be seen if/how the presence of 
proteins within the lipid bilayer affects this process.    
 
 
PURIFICATION OF MEMBRANE PROTEINS USING SMA  
Simplicity is one key advantage of SMA compared to conventional detergents for the purification 
of membrane proteins. A new purification typically begins with testing a panel of detergents for 
optimal solubilisation, and considering a similar panel for downstream processes such as 
purification, functional assays and structural characterisation[22–24]. Factors such as head groups, 
tail lengths and critical micelle concentration can have different effects on the experiment. By 
contrast, SMA provides a much more generic solution: proteins are solubilised from membranes, 
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along with a portion of lipid bilayer, as stable nanoparticles[25] that, once purified, are suitable for 
many structural and functional characterisations. Crucially, once assembled, SMALPs are very 
stable and, in contrast to micelle-forming detergents, it is not necessary to supplement buffers with 
further SMA, which makes many downstream processes technically less challenging than they are 
with conventional detergents. 
A generically-applicable protocol describing the purification method for membrane proteins using 
SMA was recently published[26]. In this protocol, SMA is used at 2.5 % (w/v) to solubilise 
membranes at 40 mg/ml wet weight, and the experiment is carried out at room temperature. 
Thereafter, the target protein can be isolated by nickel affinity chromatography including an 
overnight binding step followed by size exclusion chromatography. This method has allowed 
successful purification of a large variety of membrane proteins, including G protein-coupled 
receptors (GPCRs)[27], ATP binding cassette (ABC) proteins[9], ion channels[10] and recently, 
several membrane protein complexes[28–31]. These reports demonstrate successful solubilisation 
of membrane proteins from a range of membranes: bacterial, insect, yeast, plant and mammalian, 
and also from organelle membranes[31,32].  
Following solubilisation with SMA, nickel-affinity purification is the most widely used method to 
isolate specific protein-SMALPs[9,10,26,27,31,33–36]. Some simple modifications to standard 
nickel affinity have been necessary to adapt it for use with SMALPs - namely, the longer 
incubation of protein-SMALPs and nickel resins to ensure binding. In addition, low imidazole 
concentrations (>10 mM) can elute protein-SMALPs from nickel resins, which restricts the 
stringency of the washing for proteins with short histidine tags (≤His6). While this could be a 
concern regarding the purity of the final sample, in practice it is possible to isolate highly pure 
protein-SMALPs and in some cases the purity of samples isolated using SMA exceeds that of the 
same construct in common detergents.  
As the SMALP method becomes more widespread, and purifications of more proteins are 
attempted, new modifications and applications of the method have emerged. These demonstrate 
the fundamental versatility of protein-SMALPs, and may facilitate, amongst other things, 
solubilisation of proteins from different membranes, use of different affinity tags, and purification 
of proteins with differing stabilities. As the details of many of the initial studies have recently been 
summarised[9,10,18,27], in this section, we will discuss the most recent membrane protein 
purifications in SMA, including novel methodologies. 
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New proteins and purification methods 
The human equilibrative nucleoside transporter (hENT1/SLC29A1), an example from a class of 
membrane proteins not previously studied in SMA, was recently purified from insect cell 
membranes[37]. This study demonstrated successful use of the FLAG tag for purification of a 
SMALP-encapsulated protein, with an approximate yield of 0.4 mg hENT1 per litre of insect cell 
culture, which was about 40% of the total solubilised hENT1. Immunoaffinity chromatography 
was also used to purify the zinc diffusion facilitator CzcD via a Strep tag and the Streptactin 
resin[38]. In order to maximise the efficiency of binding of the CzcD-SMALPs to the resin, free 
SMA was removed after solubilisation by washing the solubilised material in a 50 kDa molecular 
weight cut off centrifugal filter. This purification yielded 1- 4 mg protein per litre of culture, which 
was subsequently used in an NMR study. A further antibody-based approach has been used to 
purify small quantities of the SecYEG translocon complex from its native Escherichia coli 
membranes using immunoprecipitation[30]. 
Another novel purification method demonstrated the use of an ADP-sepharose affinity purification 
to isolate the dhurrin metabolon once again from its native membrane, in this case those from 
sorghum plants[28]. This dynamic multisubunit complex was isolated along with its native lipids, 
which were extracted from the SMALPs and analysed by liquid chromatography-mass 
spectrometry. 
 
Modifications to the original SMALP protocol 
As well as reporting new purification methods for protein-SMALPs, a number of recent papers, 
including those discussed above, have described modifications to the original SMALP 
solubilisation protocol. For example, SMA has been used to solubilise the melatonin receptor 
(MT1R) from P. pastoris membranes, but this yielded less protein than a comparable detergent 
purification[35]. This corresponded to findings from other authors who showed that yeast 
membranes may be less susceptible to SMA solubilisation than those from bacteria[21]. In P. 
pastoris membranes, the yield of protein solubilised in SMA was comparable to the yield from 
detergent only at the elevated temperature of 40 °C, which resulted in unfolding of the target 
protein[35].  
In the case of hENT1, the authors observed that isolation of functional protein required the use of 
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SMA in the solubilisation step at a lower concentration than previously reported (0.25 % vs 2.5 
%). Moreover, to prevent protein degradation the solubilisation was carried out overnight at 4 °C, 
as opposed to 1-2 hour at room temperature as described in the original protocol. However, in the 
new protocol the use of protease inhibitors was not mentioned, the inclusion of which may prevent 
protein degradation and remove the need for this modification. The disadvantage of reducing the 
SMA concentration and temperature was that it reduced the solubilisation efficiency for the target 
protein to 20%, however this seems a more than reasonable compromise for obtaining pure 
samples of a functional membrane protein, and indeed the authors reported a final yield of 0.4 mg 
protein per litre of insect cell culture, which is adequate for most applications.  
To isolate functional hENT1, it was also necessary to supplement the solubilisation mixture with 
cholesteryl hemisuccinate (CHS) or asolectin lipids. Supplementation with CHS is commonly used 
in detergent solubilisation to stabilise membrane proteins[39–43], but proteins in SMALPs 
typically retain membrane lipids, so it is surprising that CHS was necessary to maintain protein 
function. Indeed the opposite observation was made for the GPCR adenosine 2A receptor (A2AR) 
purified from P. pastoris membranes[27,40]: CHS supplementation was necessary for detergent-
purified samples, but not those prepared using SMA. Doubtless as more proteins are isolated in 
SMALPs, a consensus on when and why this supplementation is necessary will eventually emerge. 
 
Identification of lipids 
An aspect of the protein solubilised by SMA is the consistent co-purification of lipids with the 
encapsulated membrane protein. Capitalising on this opportunity, several of the papers described 
above, as well as earlier publications, have described extraction and analysis of the co-purifying 
lipids, with the intention of identifying which, if any, membrane lipids are of particular importance 
to the structure and function of each protein, and indeed whether significant lipid selectivity exits. 
Such evidence is currently sparse.  
Methods employed for analysis of lipids from SMALPs include thin layer chromatography 
(TLC)[10,29,31,32,44], gas chromatography[10,28], phosphorous assays[25,36,38], and mass 
spectrometry (MS), both liquid chromatography-MS and electrospray ionisation mass 
spectrometry[29,37]. These methods offer different levels of detail about the lipids contained in 
the SMALPs, from quantification of total phospholipid or sterol content and identification of 
phospholipid type by headgroup, to detailed analysis of the chain lengths and saturations. Several 
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studies report an estimation of the number of lipids present in the nanoparticle, but to date this 
shows considerable variability.  
Lipid-only SMALPs have been estimated by theoretical calculations to contain 140 -180 lipids 
total (70-90 per leaflet)[45,46]. Phosphorus assays for lipid content within purified SMALP 
samples give values of 11 lipids per SMALP for the beta-barrel protein PagP [25], 32 lipids per 
dimer of the 34kDa protein CzcD [38], and 40 lipids per SMALP for AcrB [36]. These estimates 
suggest that the nanoparticles are only sparsely populated with lipid. This is perhaps not surprising 
for AcrB, which with 36 transmembrane helices is the largest protein encapsulated to date, but 
might be considered low for the smaller proteins. In contrast it was estimated that purified 
SMALPs containing the bacterial reaction centre contained 150 lipid molecules per reaction 
centre[44]. These differences may arise due to variability in the size of the SMALP formed, or 
technical differences in sample preparation or analysis, but the large variability suggests more data 
are needed to be certain of these methods.  
Arguably more interesting than the total number of lipids co-extracted with a membrane protein 
are the characteristics of those lipids, and whether or not a given protein associates with specific 
lipids. Analysis of lipids that co-purified with the dhurrin metabolon indicated that phosphatidyl 
choline (PC), phosphatidyl ethanolamine (PE) and phosphatidyl glycerol (PG) were enriched in 
the dhurrin metabolon-SMALPs compared to the bulk phospholipids from sorghum 
membranes[10,28]. This corresponded to results from functional assays of the detergent-purified 
metabolon subunits, which were more active when reconstituted into anionic phospholipid-
enriched liposomes. This indicates a selectivity of the dhurrin-metabolon for anionic lipids. 
The SecYEG complex displayed a preference for anionic lipids based on an analysis of the lipids 
contained within SecYEG-SMALPs[29]. In this case, lipids were extracted from SecYEG-
SMALPs using organic solvents[47], and detected by TLC and electrospray ionisation-MS. The 
enrichment of PG and cardiolipin (CL) were 40 % and 90 % higher respectively.  The ion channel 
KcsA extracted and purified with SMALPs also had higher preference for anionic lipids, 
particularly PG and CL[48]. This might hint that SMA itself had a preference for negatively 
charged lipids, but in fact in all these cases, the proportions of lipids in the total SMA-solubilised 
fraction (ie. the soluble material prior to purification)  matched those of the bulk membranes. This 
indicates that in fact, SMA does not selectively extract certain lipids.    
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Mass spectrometry offers the opportunity to derive more information than just the phospholipid 
head groups from the lipids extracted from SMALPs. For example, hENT1-SMALPs showed an 
enrichment of long chain saturated and monounsaturated PC species but an exclusion of 
polyunsaturated PE species compared to the bulk Sf9 insect cell membrane from which it was 
extracted[37]. 
Overall, these data do appear to suggest that particular proteins and lipids have preferential 
interactions. On the other hand, recent publications have reported that the lipids contained by 
SMALPs are capable of exchange, either between SMALPs and immobilised bilayers[49], or by 
rapid lipid exchange between nanodiscs[50]. However, both of these studies were undertaken 
using model membranes and lipid-only SMALPs and may not apply to protein-SMALPs. 
Nonetheless this is a question that must be settled before the findings from lipidomic studies of 
SMALPs can be regarded as definitive. 
 
 
STABILITY, STRUCTURE & FUNCTION 
Enhanced stability of membrane proteins 
One of the most common problems experienced when working with extracted and purified 
membrane proteins is their inherent lack of solubility in aqueous environments. As previously 
mentioned, detergents render membrane proteins not only soluble but also, in many cases, 
unstable, leading to an irreversible conformational change and/or aggregation. This destroys the 
structure, function and solubility of the protein, making it impossible to carry out further 
biochemical and biophysical studies.  
SMA solubilisation offers a new outlook on membrane protein instability. SMALPs remove many 
of the difficulties previously encountered in concentrating detergent-purified membrane proteins, 
where concomitant concentration of detergents often occurs, which can lead to decreased stability 
of the protein[51]. Due to the presence of lipids, it might be expected that SMA-extracted 
membrane proteins demonstrate an enhanced stability compared to detergent-purified proteins. 
Perhaps more accurately, SMALP-encapsulated proteins are able to demonstrate their inherent 
stability. This hypothesis has been investigated for several different proteins using a range of 
approaches, including gel electrophoresis[34], light scattering[34], fluorescence[9,48], 
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absorbance[44], and circular dichroism spectroscopies[10,25,27], as well as binding assays using 
radiolabeled substrates[27,37].  
Thermostability, which is the ability to resist chemical or physical structural changes at increasing 
temperatures, has been most frequently studied and it can be used as an indicator of the overall 
stability of a membrane protein [52,53]. Circular dichroism spectroscopy (CD) uses the differential 
absorption of right-handed and left-handed circularly polarised light measured over various 
wavelengths (which occurs when a molecule contains chiral groups) to examine the secondary 
structural composition of proteins and monitor unfolding. SMALP discs on their own have 
negligible CD absorbance, and unlike proteoliposomes do not scatter light significantly[25]. Using 
modern spectrometers, CD signal can be monitored as temperature increases to monitor protein 
unfolding[54].  
Using CD, it was observed that the folded structure of transmembrane protein PagP was 
maintained within SMALPs, and displayed high thermostability at maximum experimental 
temperatures of 90oC compared to proteins extracted via the detergent octyl glucoside (OG)[25]. 
CD analysis of the GPCR A2AR encapsulated in SMALPs showed secondary structural data 
consistent with solved crystal structures of this protein. Upon heating from 25oC to 95oC, A2AR 
protein gradually lost its secondary structure, leading to thermal denaturation of the protein, yet 
even at 95oC the A2AR signal had not completely transformed to that of a random coil. This 
indicates that proteins in SMALPs are the highly resistant to thermal denaturation[27]. Similarly 
the SMALP-extracted and purified ion channel KcsA was shown using CD spectroscopy to have 
markedly increased stability at high temperatures in comparison in the detergent dodecylmaltoside 
(DDM)[10]. 
Fluorescence spectroscopy has also been used to study unfolding of membrane proteins upon 
heating. Monitoring the spectral shifts of native tryptophan residues as they become more solvent 
exposed reiterated the observation that KcsA within SMALPs was more thermostable than when 
detergent (DDM) solubilised[48]. In addition, an assay which labelled cysteine residues with 
fluorophores as the protein denatures[42,52] showed that the ABC transporter P-glycoprotein 
within SMALPs had a greater than 10°C increase in apparent melting temperature compared to 
detergent (OG) purified protein [9]. 
Arguably the most important aspect of stability is functional stability. Using radioligand binding 
assays, functional thermostability has been measured for both the GPCR A2AR[27] and 
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hENT1[37]. The A2AR within SMALPs showed a marked increase in thermostability compared to 
DDM solubilised protein[27]. In addition the SMA solubilised hENT1 showed an increase in 
apparent melting temperature of 6-7°C compared to solubilisation in detergents DDM or DM  
(decyl maltoside), and was in fact more similar to that in native cells[37]. 
Other aspects of SMALP-encapsulated protein stability that have been investigated relate to 
storage conditions. How long a sample is stable under typical storage conditions such as 4°C or 
room temperature can be important for several downstream techniques. Freezing of biological 
compounds is commonly used in various industries to maintain their quality and stability, increase 
shelf life, reduce degradation over time and prevent microbial growth. However freezing and 
thawing proteins through multiple cycles can cause complex structural denaturation. Using 
radioligand binding, the GPCR A2AR solubilised in SMA was shown to have a 7-fold increase in 
half-life at the physiological temperature of 37oC, compared to A2AR in the detergent DDM. 
Moreover the stability of A2AR-SMALP at 4
oC was similar to that of native membranes with a 
half-life of > 16 days, in comparison to A2AR in DDM which had a half-life of 1.8 + 0.3 days[27]. 
Using a characteristic absorbance, SMA-purified bacterial reaction centres were also shown to 
have increased stability over time compared to detergent-purified samples at both 40°C and 
70°C[44]. Finally A2AR-SMALP showed greater resistance to repeated freeze-thaw cycles, and 
maintained its binding efficiency even after five freeze-thaw cycles on the same sample, whereas 
A2AR solubilised in DDM lost its ligand binding capacity after only a single freeze-thaw cycle[27]. 
  
Structural studies of membrane proteins within SMALPs 
Structural studies typically require stable, monodisperse, highly pure protein samples at a high 
concentration. To achieve this sample quality for membrane proteins has historically been a 
significant technical challenge. However the enhanced stability of membrane proteins within 
SMALPs, coupled with the ease of concentrating these samples, makes this system ideal for 
downstream structural studies. In fact, SMALPs are compatible with both negative stain and cryo-
electron microscopies[9,36]; X-ray crystallography[33] and solid state NMR[38,45]. 
For many years, X-ray crystallography has been the gold-standard technique for high resolution 
protein structure determination. However it is hindered by the unpredictability of crystal formation 
especially for membrane protein samples, due in part to their large membrane-spanning 
hydrophobic domains. Many membrane proteins have been crystallised from detergent micelles 
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but many targets remain difficult to purify and concentrate sufficiently for crystallisation, and for 
others there is evidence that they are not stable in detergents over the time-scales necessary for 
crystal growth [55]. With mounting evidence that protein-SMALPs retain native lipids, functional 
properties and thermal stability, there has been great optimism that this could translate to solving 
reliable structures of membrane proteins at high resolutions.  However, it remained unclear 
whether SMA could be removed from SMALPs in order to allow the close contact between 
proteins needed for crystallization, without irreversibly destabilising the proteins.  
Recently Broecker and co-workers neatly side-stepped this issue by reconstituting an α-helical 
seven transmembrane bacteriorhodopsin (29 kDa) from Haloquadratum walsbyi (HwBR) into the 
lipidic cubic phase (LCP) directly from SMALPs[33]. Crystals formed and a structure of 2.0Å 
resolution was generated (Figure 2A) that is identical to the 2.2Å detergent based structure. They 
report that crystal packing was not affected by the SMA polymer as long as the polymer 
concentration was low. Bacterial lipids were not observed in the crystal structure but had been 
replaced by the monoolein used in the lipidic cubic phase for packing. The authors hypothesise 
that lipids could be retained by the proteins, binding them tightly, but this remains to be proven. 
Nonetheless, it is possible to obtain a membrane protein structure for a protein sample that 
consistently retained a lipid environment, and is a very exciting prospect for the future. 
Equally excitingly, electron microscopy (EM) has lately ‟come of age” as a method for high-
resolution protein structure determination[56,57]. As a solution-based method, EM does not 
require crystal formation, relying instead on reconstruction of three-dimensional structures from 
two-dimensional images of single protein particles. In this case too, SMALPs have demonstrated 
their utility: single particle cryo-EM was utilised to obtain the structure of the ABC transporter P-
glycoprotein/ABCB1 (150 kDa) within SMALPs (Figure 2B)[9]. While the structure was at low 
resolution (35Å), it correlated well with the structures solved by crystallography [58,59] and 
previous EM [60]. Similarly the structure of the bacterial multidrug efflux pump AcrB, extracted 
and purified within SMALPs has been determined to 23Å using negative stain single particle EM 
(Figure 2C)[36]. The structure showed a clear 3-fold symmetry as expected from this large (≈300 
kDa) trimeric protein, and the known crystal structure correlated well with the EM envelope.  
Whilst these structures obtained within SMALPs to date are low resolution, they prove that 
SMALP-encapsulated proteins are amenable to single particle EM studies.  Recent technological 
advances in cryo-electron microscopy, such as direct electron detectors and algorithms to correct 
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for beam-induced motion mean that high resolution structures are now achievable.  This was 
highlighted by the recent 3.4Å structure of the TRPV1 ion channel reconstituted in MSP discs, so 
detailed that side-chains of amino acids were resolved[61]. The existing EM data from proteins in 
SMALPs suggest that there is great promise for the future.  
Solution NMR is not expected to be compatible with SMALPs, due to the size of the disc limiting 
the tumbling speed of the proteins. Although it has been shown that alterations in the polymer 
structure can lead to the formation of smaller nanoparticles[34], these remain to be tested. 
However, a recent study demonstrated that SMALP encapsulated proteins are amenable to atomic-
resolution studies using magic-angle-spinning solid-state NMR[38]. Using the zinc diffusion 
facilitator CzcD (34 kDa), the authors demonstrated that SMA solubilised and purified protein 
could be utilised to generate NMR spectra, with favourable line widths and potential for high 
resolution. Spectral overlap has so far prevented the residues from being fully assigned, perhaps 
due to the size of the protein. Even so, this is another promising area for the future.  
 
Functional studies on SMALP encapsulated membrane proteins 
With any new or different method, questions rightly arise about the integrity of the protein purified: 
does it retain its activity; its structure; and ability to perform its function? How do membrane 
proteins within SMALPs perform in existing assays and lend themselves to analysis by well-tested 
methods?  
The first SMALP encapsulated protein reported was PagP, an outer membrane beta-barrel with 
phospholipase activity. Its function in SMALPs was measured using NMR by detection of a 13C-
lysoPC product from 13C-labelled PC[25].  NMR was also utilised to monitor the function of a 
bacterial tyrosine kinase, ETK, within SMALPs. 19F-NMR spectra from an incorporated unnatural 
amino acid difluorotyrosine was used to measure autophosphorylation[11].  
Another early report described purification and functional analysis of the GPCR A2AR using 
radioligand binding assays. The pharmacology of A2AR was comparable when encapsulated in 
SMALPs and in the membrane[27]. More recently, purification of the ghrelin receptor and 
melatonin receptors reiterated that receptors retained their normal ligand-binding ability[35]. This 
study used a fluorescence-based assay to show that both proteins were capable of activating their 
cognate G protein, and moreover, that they could recruit arrestin in response to agonist binding 
(and conversely that this did not happen in the presence of an antagonist). 
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A Fӧrster resonance energy transfer (FRET) assay was used to monitor the activity of SecYEG 
encapsulated in SMALPs[29]. A substrate of the Sec translocon, proOmpA-DhfR-Atto532, was 
added to SecYEG-Cy5-SMALPs along with ATP. As OmpA entered the translocon, the 
fluorescence signal increased. In the presence of a non-hydrolysable analogue of ATP, this was 
not observed.  
The activity of SMALP-encapsulated complex IV (cytochrome c oxidase) purified from yeast 
mitochondria was monitored using standard spectroscopic methods[31]. The complex IV-
SMALPs displayed characteristic absorption peaks at 445 and 605 nm due to the haem groups and 
catalysed the reduction of oxygen to water. Furthermore, addition of DDM to the purified cytcO-
SMALPs actually resulted in higher activity, which has previously been shown to result from 
detergent-mediated loss of regulatory subunits from the complex. This suggests that SMA-
encapsulation may solubilise complex IV from the membrane in a more physiologically relevant 
state that standard detergent preparations, and even challenges the idea that samples with higher 
activity are necessarily most physiologically relevant.  
Conversely, the oxygen reduction assay revealed that adding high concentrations of SMA to 
equine heart mitochondria inhibited the oxidase activity of complex IV, perhaps due to SMA 
preventing binding of cytochrome c to complex IV. However, this effect was reversible, and was 
not observed in the purified complex IV samples, most likely because they contained very low 
concentrations of SMA (little or no free SMA remains beyond the solubilisation step).  
Fluorescence-based assays were also used to measure the ligand-binding ability of the ABC 
proteins P-glycoprotein/ABCB1 and BmrA. Unfortunately SMA is not compatible with standard 
assays to measure the rate of ATP hydrolysis, which is a typical measure for ABC transporter 
activity (this is discussed further in the next section). Nonetheless, the function of SMA-
encapsulated P-glycoprotein or BmrA was measured by monitoring fluorescence quenching upon 
binding of nucleotides, inhibitors and transport substrates. These all showed binding affinities 
comparable to previous reports for detergent solubilised and/or reconstituted proteins[9,34].  
Single channel activity has been recorded for the KcsA ion channel reconstituted from SMALPs 
into an E. coli planar lipid bilayer[10]. After reconstitution, the protein retained its characteristic 
conductivity, both in terms of the amplitude of the signal and open probability of the channel. The 
channel could also be reversibly blocked with tetraethylammonium. In short, the channel activity 
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of the SMALP-purified KcsA was identical to that purified by standard protocols (i.e. detergent 
followed by reconstitution into lipids). 
To conclude, in the majority of these cases standard activity assays required at most minor 
modifications in order to be used with protein-SMALPs. In addition, where a comparison is 
possible, the SMALP-encapsulated proteins typically displayed normal function compared to the 
same proteins in detergents, liposomes and even native membranes. Some limitations remain, such 
as the difficulty of detecting ATPase activity, and the effect that excess SMA has on the function 
of some proteins, but overall it can be concluded that for many proteins SMA does not have a 
deleterious effect on function, and considered with the enhancements to protein stability, may 
facilitate functional studies that have previously been impossible. This is especially true for 
delicate or dynamic protein complexes, which may be more easily isolated using SMA-
encapsulation.  
 
 
CURRENT LIMITATIONS & FUTURE DIRECTIONS 
It is clear that the SMALP approach offers many advantages over conventional detergents for 
membrane protein solubilisation and purification. However as with any new technology there are 
still many parameters to determine and some limitations to be overcome.  
 
Known limitations 
One issue is the sensitivity of the SMALP nanoparticle structure to divalent cations such as 
magnesium and calcium[34,62]. It is thought that the two carboxyls of the maleic acid groups 
chelate Mg2+, possibly inducing strain or a conformational change in the polymer surrounding the 
SMALP, and if this occurs to too many of the maleic acid groups protruding from a single SMALP 
it causes the SMA to precipitate. Without the SMA wrapped around the protein/lipid disc, it is no 
longer water soluble, leading to precipitation of the protein. For SMALPs formed with the 2:1 
SMA polymer, this occurs when the magnesium concentration exceeds approximately 4 mM, 
whereas for SMALPs formed from the 3:1 SMA polymers the threshold for magnesium is even 
lower (<1 mM)[34]. For proteins that require magnesium binding as a co-factor for nucleotide 
binding or hydrolysis, such as ATPases and G proteins this is particularly problematic. Moreover, 
it is likely that the SMA sequesters the Mg2+ at lower concentrations making it unavailable to the 
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protein, so a simple solution of restricting the concentration of magnesium below the threshold 
may not be effective. 
Similarly, SMA and SMALPs are sensitive to low pH. The pH needs to be retained above pH7 
(typically pH8 is used), otherwise the SMA precipitates out of solution. For some proteins which 
require a more acidic environment for optimal function, this can be problematic.  
Another potential limitation of the SMALP system is the size of the disc formed. Typically 
reported to have a diameter of 10-12 nm, the discs are too small for some proteins and complexes 
with large membrane spanning domains (since these domains of the protein reside in the disc, this 
characteristic, rather than the absolute molecular weight, is likely to be the limiting factor). 
However Bell et al exploited this size limitation to produce a membrane preparation highly 
enriched in their target membrane complex, photosystem I-light harvesting chlorophyll II, which 
is too large itself for incorporation into a SMALP, by using SMA to solubilise and remove most 
other smaller membrane components[63]. There are also some reports that the size of the discs 
formed are not as rigid as previously thought[28,64], and have the potential to be tuned according 
to the ratio of polymer to lipid[19,20] or the ratio of styrene:maleic acid within the polymer[65].  
Although the enhanced stability of membrane proteins within SMALPs is one of the major 
advantages of this approach, particularly in relation to structural biology, it raises the question of 
whether proteins could be ‘held too tightly’ for conformational changes to occur. It was shown 
with lipid only SMALPs that the lipid environment within SMALPs retains a very similar phase 
transition temperature to those in a larger bilayer, suggesting it is a good mimic of the natural 
environment[46]. However the lipids at the periphery of the disc which interact directly with the 
styrene moieties of the polymer are considered to be more ordered[46]. For larger membrane 
proteins where the number of lipids surrounding the protein will be more limited, and which will 
be nearer to this ordered outer layer of lipids, might this be a problem? For example for ABC 
transporters which typically have 12 transmembrane helices, and are known to undergo large scale 
conformational changes within the transmembrane domains in response to nucleotide binding and 
hydrolysis in their cytosolic domains, is there enough space or flexibility within the SMALP to 
accommodate these movements? To date it has not been possible to answer that question since the 
ATP hydrolysis required to drive these conformational changes requires magnesium binding. 
However, it is an important area to investigate in the future. Novel polymers which address the 
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magnesium sensitivity may be the answer. Alternatively, production of larger disc sizes such that 
there is more fluid lipid bilayer surrounding the protein may help. 
Finally, whilst the small disc structure is perfect for binding assays since both sides of the 
membrane are freely available, and are also compatible with spectroscopic techniques, they are 
not amenable to measuring movement of substrates across a bilayer, either by a transporter or ion 
channel, where defined, separate compartments are required. Can the SMA be removed and the 
encapsulated proteins reconstituted into proteoliposomes or other lipid bilayer systems? It has 
previously been shown that the ion channel KcsA purified within SMALPs can be added to a 
planar bilayer system and insert into the membrane to enable single channel conductivity 
measurements[10]. However it was not clear what happened to the SMA, whether it intercalated 
into the bilayer, remained associated with the protein or not. Also this style of assay requires only 
a single SMALP to reconstitute into the bilayer, and the question remained whether larger numbers 
could be reconstituted in bulk into proteoliposomes. Studies using lipids only with SMA suggest 
that the formation of SMALPs from liposomes is a reversible process and under the right 
conditions it should be possible to reconstitute SMALPs into liposomes[19]. Most importantly the 
recent incorporation of SMALP purified protein into lipidic cubic phase showed that it is indeed 
possible to transfer large amounts of protein from SMALPs into another bilayer system [33], and 
this is highly promising for the future. 
 
Exploring SMA variants and novel polymers  
Modifications to the polymer structure may provide solutions to the current limitations. To begin 
with, there are already many styrene-maleic acid polymers with varying sizes and ratios of 
styrene:maleic acid. These display variations in their ability to solubilise membranes, their 
sensitivity to ionic strength and pH, and the size of discs they form[34,66]. Strictly alternating 
SMA polymers also exist (called RAFT polymers after the polymerisation process used to produce 
them)[16,65,67]. These provide a well-defined comparison to the industrial SMAs that are 
currently in use 
In terms of the pH sensitivity of SMA, a partial solution already exists in the form of styrene maleic 
imide (SMI), a polymer soluble below pH 6 [68], that like SMA can solubilise lipids[69,70]. 
It has previously been demonstrated that SMA can be modified by reaction with cysteamine which 
replaces one of the maleic acid carboxyl groups with an amide (SMA-SH), creating a modified 
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SMA polymer which is still capable of solubilising membranes and forming discs[71].  With fewer 
carboxyl groups, this modified polymer may be less able to chelate the divalent cation and thus 
less sensitive to magnesium, however this remains to be determined. Interestingly, it was recently 
reported that a di-isobutylene maleic acid (DIBMA) copolymer, which contains a linear carbon 
chain instead of the cyclic styrene group, is also capable of solubilising membranes. Discs formed 
from DIBMA are tolerant to much higher concentrations of calcium or magnesium, in excess of 
25mM[62]. This is particularly interesting since this polymer still contains the maleic acid groups, 
but perhaps other features of the polymer structure mean that binding divalent cations does not 
induce the same strain as seen with SMA.  
 
Future directions 
The future directions for the field are wide-ranging, falling into two broad areas. The first is 
continuing to exploit the remarkable ability of SMA to solubilise and stabilise membrane proteins 
for study. The second is to explore the properties of SMA, to better understand how it works and 
possibly to use this mechanistic insight to design new polymers, or to refine the ones currently 
available. 
In terms of protein purification, we have many examples of initial successes, for instance the first 
purifications from several classes of membrane proteins, functional purification of GPCRs, the 
first high-resolution structure determination of a protein purified using SMA, and lipidomic profile 
from protein-SMALPs. It is a proven method for many proteins and expression systems. We now 
need time to amass more data and critically assess whether the potential of SMA delivers in some 
or all areas. Developments in polymer chemistry and scaling-up the productions of polymers that 
are well-characterised in terms of composition and length will most likely play a part in this and 
allow us to better understand the mechanism of SMALP formation. However, these developments 
may also represent a change in the philosophy of purification of membrane proteins with SMA. At 
present it is a cheap and plentiful chemical that does a difficult job with remarkable simplicity and 
success. Will pursuing alternative polymers open up new chemical space and enable us to reach 
all membrane proteins, or will it lead us to dead ends, or a situation analogous with traditional 
detergents, in which a range of SMAs (or other polymers) are screened?  
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Conclusion 
The encapsulation of membrane proteins in SMALPs is beginning to find wide applications as a 
research tool. SMA provides an attractive alternative to conventional detergents for membrane 
protein purification, and offers significant advantages, principally enhanced protein stability. The 
method is compatible with many established purification methods and biophysical 
characterisations, and there is increasing evidence that many functional and structural analyses are 
also compatible with protein-SMALPs. Indeed, for some proteins these analyses have been 
facilitated by SMA when they were previously challenging, or impossible. Particularly notable in 
the success of this method for structural studies is that it is applicable to methods such as cryo-EM 
and X-ray crystallography. Indeed the recent crystal structure is the first demonstration that atomic 
level diffraction data can be achieved from a membrane protein crystallized from a SMALP. 
Furthermore the opportunities to study the interactions between membrane proteins and their 
native lipids in pure samples is currently unmatched by other methods. Of course, this method 
remains relatively new and frustratingly there are many questions that we cannot yet answer. 
Nonetheless the SMALP encapsulation method provides many promising opportunities and 
possibilities for the future of membrane protein research. 
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FIGURE LEGENDS 
 
Figure 1. Schematic of SMA mediated membrane protein solubilisation and purification. SMA 
is added to extracted membrane preparations where it inserts and forms small, soluble 
nanoparticles, SMALPs, containing proteins and lipid bilayer surrounded by polymer. The cloudy 
suspension of membranes turns to a clear solution. SMALPs containing membrane proteins of 
interest can be purified by affinity chromatography, enabling solubilisation and purification of 
membrane proteins without ever removing them from a lipid bilayer environment. 
 
Figure 2.  Membrane protein structures determined using SMA solubilisation and purification. 
A; Structure of HwBR determined by x-ray crystallography using HwBR solubilised and purified 
in SMA before incorporation into lipidic cubic phase to generate crystals (PDB ID: 5ITC). 
Crystals diffracted to a resolution better than 2 Å. This structure was originally published in 
Broecker et al (2017) Structure 25; 384-392[33]. B. Refined envelope of SMA solubilised P-
glycoprotein/ABCB1 obtained using single particle cryo-EM (yellow net) with the crystal structure 
(PDB ID: 3G5U) docked within it (blue ribbon). The refined structure was estimated to be at 
approximately 35 Å resolution. This figure was originally published in Gulati S et al (2014) 
Biochem J. 461; 269-278[9].  C; Surface view of the reconstruction from negative stain single 
particle EM of SMA solubilised AcrB, with the crystal structure (PDB ID: 1IWG) fitted into it. 
Resolution of 23 Å. This figure was originally published in Postis V et al (2015) BBA 
Biomembranes 1848; 496-501[36].  
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